DE
36
-2
EMC
53
-3
PX
73
-6
FTI
78
-3
MRO
46
3
IP
70
-3
CHD
48
-3
STI
31
19
WDC
38
-3
CTSH
65
-3
PSX
47
3
QRVO
4
-2
GOOG
69
-10
PCG
99
2
RIG
44
-2
CVX
38
6
SRE
66
-3
ABT
57
-5
SYY
47
-2
NOV
58
-2
DE
36
-2
EMC
53
-3
PX
73
-6
FTI
78
-3
MRO
46
3
IP
70
-3
CHD
48
-3
STI
31
19
WDC
38
-3
CTSH
65
-3
PSX
47
3
QRVO
4
-2
GOOG
69
-10
PCG
99
2
RIG
44
-2
CVX
38
6
SRE
66
-3
ABT
57
-5
SYY
47
-2
NOV
58
-2
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
78

TGTX
TG Therapeutics

Last Price:
30.84
Seasonality Move:
46.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

TG Therapeutics Price Quote

$30.84
-4.05 (-11.61%)
(Updated: November 14, 2024 at 5:55 PM ET)

TG Therapeutics Key Stats

Buy
78
TG Therapeutics (TGTX) is a Buy
Day range:
$29.84 - $36.24
52-week range:
$10.42 - $32.48
Dividend yield:
0%
P/E ratio:
343.56
P/S ratio:
18.17
P/B ratio:
25.05%
Volume:
9.9M
Avg. volume:
3.3M
1-year change:
240.39%
Market cap:
$4.8B
Revenue:
$233.7M
EPS:
$-0.11

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.49%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.97%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 57.3% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 240.39% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $341M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.23

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is $67.8M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $565K
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$82.5M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is -5.71%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -3.55%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is -8.4%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Precision BioSciences Inc (DTIL)
    • Inspire Medical Systems Inc (INSP)
    • Rhythm Pharmaceuticals Inc (RYTM)
    • Varex Imaging Corp (VREX)

TG Therapeutics Dividend Yield

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: -97.26% -40.92%
Revenue: -49.41% 2.66%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 37.22
Upside from Last Price: 6.68%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    169.3M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22.1M TGTX shares are owned by insiders